NIH Funding Explained
The National Institutes of Health (NIH) has been the quiet powerhouse fueling America’s biomedical research engine. With a hefty annual budget ($47 billion in 2025), NIH funds everything from basic biology to life-saving therapies, making it a critical player in medical innovation.
How It Works
NIH funding falls into two buckets:
- Intramural research – In-house science conducted by NIH’s own researchers at its Maryland headquarters.
- Extramural research – NIH’s real superpower. Over 80% of its budget goes to universities, hospitals, biotech startups, and research institutions across the U.S.
For Entrepreneurs
Small businesses aren’t left out. NIH runs two grant programs designed to turn bright biotech ideas into commercial products:
- Small Business Innovation Research (SBIR) – Funds early-stage research with commercial potential.
- Small Business Technology Transfer (STTR) – Similar but requires a partnership with a research institution.
Cocktail Fodder
A whopping 174 Nobel laureates have received NIH funding at some point in their careers. That includes game-changing discoveries like CRISPR gene editing and mRNA vaccines, which started with NIH-backed research long before they became household names.
The Impact
NIH-backed research has:
- Led to major drug discoveries. 99.4% of FDA-approved drugs trace their origins to NIH funding from 2010 to 2019.
- Fueled biotech startups. SBIR/STTR-funded companies have brought over 700 life-saving products to market.
- Supercharged public health. From COVID-19 vaccines to cancer breakthroughs, NIH investments ripple across medicine.
Funding Freezes and Layoffs
The current administration ordered a suspension of NIH grant funding on January 27, 2025, effectively freezing much of its $47 billion budget. Consequently, the NIH announced layoffs affecting approximately 1,000 to 1,200 workers on February 15, 2025. These significant challenges have prompted widespread concern about the future of scientific research and public health in the United States.
The Bottom Line
NIH funding is America’s secret weapon in the global race for medical innovation. It de-risks early-stage research, supports brilliant minds, and ensures the next generation of cures gets off the ground. Without it, biotech’s pipeline of breakthroughs will slow to a trickle, and patients lose.
Empower Yourself!
Join us and Life Science Washington on May 20-21, 2025 for BioBasics 101: The Biology of Biotech for the Non-Scientist!
- Speak the Language of Biotech – Gain confidence in essential life science terminology to navigate the industry like a pro.
- Decode the Blueprint of Life – Understand the roles of DNA, RNA, and proteins in health and disease and how they shape medical advancements.
- Unlock the Future of Medicine – Discover how genomics and proteomics are revolutionizing personalized treatments for genetic diseases.
- Harness the Immune System – Learn how cutting-edge therapies work to fight disease and transform patient outcomes.
